MRD Status Predicts Outcomes in Patients With Previously Untreated FL
Researchers sought to determine whether MRD status would be predictive of outcomes after induction and during maintenance in previously untreated patients with FL.
Researchers sought to determine whether MRD status would be predictive of outcomes after induction and during maintenance in previously untreated patients with FL.
Low diagnostic value seen as independent test and supplementary measure to PSA for detection of prostate cancer.
Researchers sought to determine the effects of financial toxicity for patients treated for hematologic malignancies in a universal healthcare setting.
Fulvestrant alone or in combination with anastrozole did not provide a benefit over anastrozole alone as neoadjuvant therapy for postmenopausal, ER-rich, HER2-negative, stage II-III breast cancer.
Researchers sought to determine whether golidocitinib would have antitumor activity among patients with relapsed/refractory PTCL.
The United States has the lowest number of people giving blood observed over the past 20 years.
Researchers explored the cardioprotective properties of carvedilol in survivors of childhood cancer who are at high risk for heart failure.
Immune checkpoint inhibitor treatment may increase the risk of tuberculosis reactivation or latent tuberculosis infection in patients with cancer.
Researchers sought to determine whether adding sorafenib to chemotherapy would improve survival in patients with FLT3-ITD AML.
Highest cumulative risks for invasive breast cancer and breast cancer death seen for women aged younger than 45 years at diagnosis.